Related Experiment Video
Updated: May 22, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
[Non-muscle invasive transitional cell carcinoma of the bladder. New developments in diagnostics and therapy]
M Sommerauer1, D Jocham, J M Laturnus
1Klinik und Poliklinik für Urologie, UK-SH Campus Lübeck, Ratzeburgerallee 160, 23568 Lübeck. martin.sommerauer@uk-sh.de
Abstract:
Due to the high incidence and recurrence rate non-muscle invasive bladder cancer (NMIBC) has a relevant impact. Raman spectroscopy and optical coherence tomography represent innovative diagnostic tools. Urine markers still play a minor role in the diagnostics of NMIBC. New therapeutic options are thermochemotherapy and mitomycin-C electromotive drug administration (MMC-EMDA) as well as gemcitabine and apaziquone for intravesical administration.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Imaging Studies III: Computed Tomography
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
